Novo Nordisk A/S

(NVO) Trade

By |

Profile

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Contact Information

Website: www.novonordisk.com
Email: phak@novonordisk.com
Main Phone: +45 44448888
Address: Novo Alle 1
City / Town: Bagsvaerd
Country: DNK
Postal Code: DK-2880

Issuer Information

Exchange: NYE
CEO: Lars Fruergaard Jorgensen
Employees: 43258
NAICS: Pharmaceutical P

Equities News

View More

Profile

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Contact Information

Website: www.novonordisk.com
Email: phak@novonordisk.com
Main Phone: +45 44448888
Address: Novo Alle 1
City / Town: Bagsvaerd
Country: DNK
Postal Code: DK-2880

Issuer Information

Exchange: NYE
CEO: Lars Fruergaard Jorgensen
Employees: 43258
NAICS: Pharmaceutical P

Equities News

View More
$ 63.85 $ 0.34 (0.54%)
Last Price 63.85 Change $ 0.34 Change % 0.54 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 63.74 High 64.05 Low 63.52 Prev Close 63.51
Last Trade Volume 873,502 52 Wk Hi 64.82 52 Wk Low 46.48
Market Cap 150 bi Ex-Div Date Div Rate 1.57 Yield 2.4660
Shares 2,349,171,507.00 EPS (TTM) 2.42 PE Ratio 25.40 Exchange NYSE
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 60.4 60.4 60.4 60.4
Low Target Price Estimate 60.4 60.4 60.4 60.4
Mean Target Price Estimate 60.4 60.4 60.4 60.4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/29/18 05/29/18 05/03/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.13 2.13 2.3